Baxter International BAX Increase (Decrease) in Accounts Receivable
Increase (Decrease) in Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Baxter International in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.
The official record: Baxter International’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Baxter International's increase (decrease) in accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Baxter International's increase (decrease) in accounts receivable?
- Baxter International (BAX) reported increase (decrease) in accounts receivable of -$152M in Q1 2026.
- How has Baxter International's increase (decrease) in accounts receivable changed year-over-year?
- Baxter International's increase (decrease) in accounts receivable decreased by 484.6% year-over-year, from -$26M to -$152M.
- What does increase (decrease) in accounts receivable mean?
- The change in money owed to the company by customers during the period.
- How do you interpret increase (decrease) in accounts receivable?
- An increase in receivables relative to sales can signal aggressive revenue recognition or deteriorating customer payment cycles, while a decrease indicates strong cash collection.
- How does increase (decrease) in accounts receivable compare across companies?
- Monitored closely against Days Sales Outstanding (DSO) metrics across the medical device and healthcare supply industry.